4.7 Article

Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway

Ming Zhang et al.

Summary: In summary, CBR3-AS1 plays a critical role in the chemotherapy resistance of breast cancer by mediating the miR-25-3p and MEK4/JNK1 regulatory axes. The potential of CBR3-AS1 as a targetable oncogene and therapeutic biomarker of breast cancer was identified.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Review Cell Biology

Gene regulation by long non-coding RNAs and its biological functions

Luisa Statello et al.

Summary: Recent studies have shed new light on the biogenesis and functions of long non-coding RNAs (lncRNAs), showcasing their diverse roles in gene regulation and signaling pathways, particularly in the contexts of neuronal disorders, immune responses, and cancer. The discovery of unique biogenesis pathways and subcellular localizations of lncRNAs has opened up potential therapeutic avenues for targeting lncRNAs in various biological and pathophysiological conditions.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)

Article Cell Biology

Oxidative stress activates NORAD expression by H3K27ac and promotes oxaliplatin resistance in gastric cancer by enhancing autophagy flux via targeting the miR-433-3p

Jizhao Wang et al.

Summary: This study reveals that oxaliplatin resistance is potentially driven by oxidative stress-induced DNA damage repair response activating autophagy flux. The long non-coding RNA NORAD may play a crucial role in regulating autophagy and oxidative stress in the context of oxaliplatin resistance, indicating its potential as a biomarker and therapeutic target.

CELL DEATH & DISEASE (2021)

Review Genetics & Heredity

The Scope of Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH) in Cancer Clinicopathology: A Review

Maheen Khan et al.

Summary: AEG-1 has been established as a crucial oncogene in various types of cancer, playing a significant role in regulating cancer progression through multiple mechanisms. Clinical studies have shown that AEG-1 can serve as an independent biomarker for aggressive and chemoresistant metastatic disease.
Article Chemistry, Medicinal

Novel CK2-Specific Pt(II) Compound Reverses Cisplatin-Induced Resistance by Inhibiting Cancer Cell Stemness and Suppressing DNA Damage Repair in Non-small Cell Lung Cancer Treatments

Yuanjiang Wang et al.

Summary: The CK2 inhibitor HY1 was found to effectively inhibit cancer stem cells in non-small cell lung cancer (NSCLC), and a Pt(II) agent (HY1-Pt) was developed to reverse cisplatin-induced drug resistance. HY1-Pt targets CK2, suppresses DNA damage repair, enhances cellular accumulation of platinum, and inhibits CSCs through the Wnt/beta-catenin signal pathway. In vivo studies show that HY1-Pt has promising pharmacokinetics and higher tumor growth inhibitory efficacy with lower toxicity compared to cisplatin.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Oncology

Multifunctional Role of Astrocyte Elevated Gene-1 (AEG-1) in Cancer: Focus on Drug Resistance

Debashri Manna et al.

Summary: Chemotherapy is a major treatment for cancers, but cancer cells often develop resistance through genetic and epigenetic alterations, allowing them to adapt to environmental stresses and treatment pressures. The oncogene AEG-1 plays a significant role in promoting tumorigenesis and chemoresistance in various cancers. Understanding the molecular mechanisms of AEG-1 could provide insights into overcoming chemoresistance in aggressive cancers.

CANCERS (2021)

Review Oncology

Role of Long Non-Coding RNAs in Conferring Resistance in Tumors of the Nervous System

Soudeh Ghafouri-Fard et al.

Summary: Tumors of the nervous system can originate from various locations and have high mortality and morbidity rates. Long non-coding RNAs (lncRNAs) play a role in influencing the responsiveness of glioma/glioblastoma and neuroblastoma to chemotherapy, aiding in the design of more effective therapeutic regimens.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

RNA in cancer

Gregory J. Goodall et al.

Summary: Recent findings have shown that RNA processing is systematically altered in cancer, with mutations in RNA splicing factor genes and the shortening of 3' untranslated regions widely observed. Additionally, evidence suggests that other types of RNAs, including circular RNAs, can contribute to tumorigenesis.

NATURE REVIEWS CANCER (2021)

Article Biochemistry & Molecular Biology

SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer

Jiali Wang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Article Biochemistry & Molecular Biology

NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis

Qiang Huang et al.

BIOSCIENCE REPORTS (2020)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Biochemistry & Molecular Biology

Role of non-coding RNAs and RNA modifiers in cancer therapy resistance

Xinyi Zhang et al.

MOLECULAR CANCER (2020)

Article Cell Biology

LncRNA DHRS4-AS1 Inhibits the Stemness of NSCLC Cells by Sponging miR-224-3p and Upregulating TP53 and TET1

Fei Yan et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Chemistry, Medicinal

JNK signaling in cancer cell survival

Qinghua Wu et al.

MEDICINAL RESEARCH REVIEWS (2019)

Review Oncology

Metadherin: A Therapeutic Target in Multiple Cancers

Gourav Dhiman et al.

FRONTIERS IN ONCOLOGY (2019)

Article Medicine, Research & Experimental

Drug Resistance-Related Competing Interactions of lncRNA and mRNA across 19 Cancer Types

Haizhou Liu et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Article Biochemistry & Molecular Biology

circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling

Xueting Hu et al.

MOLECULAR CANCER (2019)

Article Gastroenterology & Hepatology

Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells

Takashi Kijima et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Oncology

LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1

Zhi-wei Chang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Article Multidisciplinary Sciences

The NORAD lncRNA assembles a topoisomerase complex critical for genome stability

Mathias Munschauer et al.

NATURE (2018)

Article Oncology

NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma

Xiaoliang Wu et al.

ONCOLOGY RESEARCH AND TREATMENT (2017)

Article Oncology

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors

Aditya Bagrodia et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Review Biochemistry & Molecular Biology

Linking Long Noncoding RNA Localization and Function

Ling-Ling Chen

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Article Multidisciplinary Sciences

A conserved abundant cytoplasmic long noncoding RNA modulates repression by Pumilio proteins in human cells

Ailone Tichon et al.

NATURE COMMUNICATIONS (2016)